Top

Journal of Diabetes & Metabolic Disorders

Published in:

01-06-2021 | Sitagliptin | Research article

Impact of combined therapy of mesenchymal stem cells and sitagliptin on a metabolic syndrome rat model

Authors: Yossra Ahmed, Zeinab Y. Ali, Mona A. Mohamed, Laila A. Rashed, Ehsan K. Mohamed

Published in: Journal of Diabetes & Metabolic Disorders | Issue 1/2021

Abstract

Background

Emerging evidence suggests that mesenchymal stem cells (MSCs) have many anti-inflammatory and regenerative properties, which makes it a suitable candidate for the treatment of many diseases including metabolic syndrome (MetS). However, a major difficulty with stem cell therapy is to maintain cell viability, properties and function after implantation in vivo. This study aims to test the hypothesis that the combined therapy of MSCs and sitagliptin can effectively ameliorate MetS complications induced by high-fat and high-fructose diet (HFFD) in rats.

Methods

Rats were fed either standard diet (Control group) or HFFD. After 3 months, a group of HFFD animals was injected by a single dose of MSCs, another group received a daily oral dose of 10 mg/kg b.w. of sitagliptin, and the third group received the combined therapy of MSCs + sitagliptin for 1 month.

Results

Both MSCs and sitagliptin restored insulin sensitivity and reduced the HOMA-IR value in HFFD rats. The hepatic IRS-1 and Akt at both gene and protein levels, as well as the hepatic protein levels of IR and GLUT4 were improved. Downregulation of CHOP and NF-κB and upregulation of hepatic HO-1 expression and activity were also reported. Although MSCs and sitagliptin as monotherapy lead to remarkable effects, the dual application revealed the best results. Interestingly, histological findings confirmed these protective effects of the combined therapy against MetS complications.

Conclusion

Combined therapy of MSCs and sitagliptin can efficiently ameliorate the insulin resistance and promote the regeneration of hepatocytes in the metabolic syndrome rat model.

Bocarsly ME, Powell ES, Avena NM, Hoebel BG. High-fructose corn syrup causes characteristics of obesity in rats: increased body weight, body fat and triglyceride levels. Pharmacol Biochem Behav. 2010;97:101–6. https://doi.org/10.1016/j.pbb.2010.02.012.CrossRefPubMedPubMedCentral

Heyn PC, Tagawa A, Pan Z, Thomas S, Carollo JJ. Prevalence of metabolic syndrome and cardiovascular disease risk factors in adults with cerebral palsy. Dev Med Child Neurol. 2019;61:477–83. https://doi.org/10.1111/dmcn.14148.CrossRefPubMed

McCracken E, Monaghan M, Sreenivasan S. Pathophysiology of the metabolic syndrome. Clin Dermatol. 2018;36:14–20. https://doi.org/10.1016/j.clindermatol.2017.09.004.CrossRefPubMed

Rameshrad M, Razavi BM, Ferns GA, Hosseinzadeh H. Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning. DARU J Pharm Sci. 2019;27:341–60. https://doi.org/10.1007/s40199-019-00238-7.CrossRef

Moll G, Hoogduijn MJ, Ankrum JA. Safety, efficacy and mechanisms of action of mesenchymal stem cell therapies. Front Immunol. 2020;11:243. https://doi.org/10.3389/fimmu.2020.00243.CrossRefPubMed

Shen H, Zhou E, Wei X, Fu Z, Niu C, Li Y, et al. High-density lipoprotein promotes proliferation of adipose-derived stem cells via S1P1 receptor and Akt, ERK1/2 signal pathways. Stem Cell Res Ther. 2015;6:95. https://doi.org/10.1186/s13287-015-0090-5.

Lee CW, Hsiao WT, Lee OK. Mesenchymal stromal cell-based therapies reduce obesity and metabolic syndromes induced by a high-fat diet. Transl Res. 2017;182:61–74.e8. https://doi.org/10.1016/j.trsl.2016.11.003.CrossRefPubMed

Lozano I, Van der Werf R, Bietiger W, et al. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab. 2016;13:15. https://doi.org/10.1186/s12986-016-0074-1.CrossRef

Jaiswal N, Haynesworth S, Caplan A, Bruder S. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997;64:295–312 PMID:9027589.CrossRef

10.

Antunes LC, Elkfury JL, Jornada MN, Foletto KC, Bertoluci MC. Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch Endocrinol Metab. 2016;60:138–42. https://doi.org/10.1590/2359-3997000000169.CrossRefPubMed

11.

Belfield A, Goldberg GM. Revised assay for serum phenylphosphatase activity using 4-amino antipyrine. Enzyme. 1971;12:561–73. https://doi.org/10.1159/000459586.CrossRefPubMed

12.

Berth M, Delanghe J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin Belg. 2004;59:263–73. https://doi.org/10.1179/acb.2004.039.CrossRefPubMed

13.

Gornal AG, Bardawil CJ, David MM. Determination of serum proteins by means of biuret reaction. J Biol Chem. 1949;177:751–66 PMID:18110453.CrossRef

14.

Bezerra RM, Ueno M, Silva MS, et al. A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr. 2000;130:1531–5. https://doi.org/10.1093/jn/130.6.1531.CrossRefPubMed

15.

Xia ZW, Zhou WP, Cui WJ, Zhang XH, Shen QX, Li YZ, et al. Structure prediction and activity analysis of human heme oxygenase-1 and its mutant. World J Gastroenterol. 2004;10:2352–6. https://doi.org/10.3748/wjg.v10.i16.2352.

16.

Ye J. Mechanisms of insulin resistance in obesity. Front Med. 2013;7:14–24. https://doi.org/10.1007/s11684-013-0262-6.CrossRefPubMedPubMedCentral

17.

Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models to disease mechanisms. J Endocrinol. 2014;220:T1–T23. https://doi.org/10.1530/JOE-13-0327.CrossRefPubMedPubMedCentral

18.

Bermudez V, Salazar J, Martínez MS, Chávez-Castillo M, Olivar LC, Calvo MJ, et al. Prevalence and associated factors of insulin resistance in adults from Maracaibo City, Venezuela. Adv Prev Med. 2016;2016:9405105–13. https://doi.org/10.1155/2016/9405105.

19.

Tran LT, Yuen VG, McNeill JH. The fructose-fed rat: a review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem. 2009;332:145–59. https://doi.org/10.1007/s11010-009-0184-4.CrossRefPubMed

20.

Zhuhua Z, Zhiquan W, Zhen Y, Yixin N, Weiwei Z, Xiaoyong L, et al. A novel mice model of metabolic syndrome: the high-fat-high-fructose diet-fed ICR mice. Exp Anim. 2015;64:435–42. https://doi.org/10.1538/expanim.14-0086.

21.

Jeong O, Kim H. Dietary chokeberry and dried jujube fruit attenuates high-fat and high-fructose diet-induced dyslipidemia and insulin resistance via activation of the IRS-1/PI3K/Akt pathway in C57BL/6 J mice. Nutr Metab. 2019;16:1–16. https://doi.org/10.1186/s12986-019-0364-5.CrossRef

22.

Yang Z, Li K, Yan X, Dong F, Zhao C. Amelioration of diabetic retinopathy by engrafted human adipose-derived mesenchymal stem cells in streptozotocin diabetic rats. Graefes Arch Clin Exp Ophthalmol. 2010;248:1415–22. https://doi.org/10.1007/s00417-010-1384-z.CrossRefPubMed

23.

Ammar HI, Sequiera GL, Nashed MB, Ammar RI, Gabr HM, Elsayed HE, et al. Comparison of adipose tissue- and bone marrow- derived mesenchymal stem cells for alleviating doxorubicin-induced cardiac dysfunction in diabetic rats. Stem Cell Res Ther. 2015;6:148. https://doi.org/10.1186/s13287-015-0142-x.

24.

Hu J, Wang Y, Wang F, Wang L, Yu X, Sun R, et al. Effect and mechanisms of human Wharton's jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model. Endocrine. 2015;48:124–34. https://doi.org/10.1007/s12020-014-0219-9.

25.

Zhou Y, Hu Q, Chen F, Zhang J, Guo J, Wang H, et al. Human umbilical cord matrix-derived stem cells exert trophic effects on beta cell survival in diabetic rats and isolated islets. Dis Model Mech. 2015;8:1625–33. https://doi.org/10.1242/dmm.021857.

26.

Xie Z, Hao H, Tong C, Cheng Y, Liu J, Pang Y, et al. Human umbilical cord-derived mesenchymal stem cells elicit macrophages into an anti-inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats. Stem Cells. 2016;34:627–39. https://doi.org/10.1002/stem.2238.

27.

Pawar AS, Eirina A, Tanga H, et al. Upregulated tumor necrosis factor-α transcriptome and proteome in adipose tissue-derived mesenchymal stem cells from pigs with metabolic syndrome. Cytokine. 2020;130:155080. https://doi.org/10.1016/j.cyto.2020.155080.CrossRefPubMed

28.

Bueno PD, Yochite JN, Derigge-Pisani GF, et al. Metabolic and pancreatic effects of bone marrow mesenchymal stem cells transplantation in mice fed high-fat diet. PLoS One. 2015;10:1–18. https://doi.org/10.1371/journal.pone.0124369.CrossRef

29.

Sohni A, Verfaillie CM. Mesenchymal stem cells migration homing and tracking. Stem Cells Int. 2013;2013:130763–8. https://doi.org/10.1155/2013/130763.CrossRefPubMedPubMedCentral

30.

Abd El-Fattah AI, Zaghloul MS, Eltablawy NA, Rashed LA. α-Lipoic acid and amlodipine/perindopril combination potentiate the therapeutic effect of mesenchymal stem cells on isoproterenol induced cardiac injury in rats. Biochimie. 2019;156:59–68. https://doi.org/10.1016/j.biochi.2018.10.002.CrossRefPubMed

31.

Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799–806. https://doi.org/10.1038/414799a.CrossRefPubMed

32.

Copps KD, White MF. Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia. 2012;55:2565–82. https://doi.org/10.1007/s00125-012-2644-8.CrossRefPubMedPubMedCentral

33.

Mohamed MA, Ahmed MA, Abd Elbast SA, Ali NA. Rice bran oil ameliorates hepatic insulin resistance by improving insulin signaling in fructose fed-rats. J Diabetes Metab Disord. 2019;18:89–97. https://doi.org/10.1007/s40200-019-00394-2.CrossRefPubMedPubMedCentral

34.

Hughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, et al. Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol. 2013;12:128. https://doi.org/10.1186/1475-2840-12-128.CrossRefPubMed

35.

Nakatani Y, Kaneto H, Kawamori D, Yoshiuchi K, Hatazaki M, Matsuoka TA, et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem. 2005;280:847–51. https://doi.org/10.1074/jbc.M411860200.

36.

Lee MR, Bae SJ, Kim JE, Song BR, Choi JY, Park JJ, et al. Inhibition of endoplasmic reticulum stress in high-fat-diet-induced obese C57BL/6 mice: efficacy of a novel extract from mulberry (Morus alba) leaves fermented with Cordyceps militaris. Lab Anim Res. 2018;34:288–94. https://doi.org/10.5625/lar.2018.34.4.288.

37.

Li B, Leung JC, Chan LY, et al. Amelioration of endoplasmic reticulum stress by mesenchymal stem cells via hepatocyte growth factor/c-met signaling in obesity-associated kidney injury. Trans Med. 2019;8:898–910. https://doi.org/10.1002/sctm.18-0265.CrossRef

38.

Zhu W, Niu X, Wang M, Li Z, Jiang HK, Li C, et al. Endoplasmic reticulum stress may be involved in insulin resistance and lipid metabolism disorders of the white adipose tissues induced by high-fat diet containing industrial trans-fatty acids. Diabetes Metab Syndr Obes. 2019;12:1625–38. https://doi.org/10.2147/DMSO.S218336.

39.

Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11:381–9. https://doi.org/10.1038/sj.cdd.4401373.CrossRefPubMed

40.

Suzuki T, Gao J, Ishigaki Y, Kondo K, Sawada S, Izumi T, et al. ER stress protein CHOP mediates insulin resistance by modulating adipose tissue macrophage polarity. Cell Rep. 2017;18:2045–57. https://doi.org/10.1016/j.celrep.2017.01.076.

41.

Theiss HD, Gross L, Vallaster M, David R, Brunner S, Brenner C, et al. Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction. Int J Cardiol. 2013;168:3359–69. https://doi.org/10.1016/j.ijcard.2013.04.121.

42.

Wang XM, Yang YJ, Wu YJ, Zhang Q, Qian HY. Attenuating hypoxia-induced apoptosis and autophagy of Mesenchymal stem cells: the potential of Sitagliptin in stem cell-based therapy. Cell Physiol Biochem. 2015;37:1914–26. https://doi.org/10.1159/000438552.CrossRefPubMed

43.

Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A. Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem. 1993;268:26055–8 PMID: 8253716.CrossRef

44.

Tilg H, Moschen AR. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med. 2008;14:222–31. https://doi.org/10.2119/2007-00119.Tilg.CrossRefPubMed

45.

Torres S, Fabersani E, Marquez A, Gauffin-Cano P. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. Eur J Nutr. 2019;58:27–43. https://doi.org/10.1007/s00394-018-1790-2.CrossRefPubMed

46.

Ndisang JF, Jadhav A. Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinol. 2009;150:2627–36. https://doi.org/10.1210/en.2008-1370.

47.

Ndisang JF, Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab 2009;296:E829-E841. https://doi.org/10.1152/ajpendo.90783.2008.

48.

Abraham NG, Junge JM, Drummond GS. Translational significance of Heme Oxygenase in obesity and metabolic syndrome. Trends Pharmacol Sci. 2016;37:17–36. https://doi.org/10.1016/j.tips.2015.09.003.CrossRefPubMed

49.

Ndisang JF, Lane N, Jadhav A. The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinol. 2009;150:2098–108. https://doi.org/10.1210/en.2008-0239.CrossRef

50.

Ndisang JF, Lane N, Syed N, Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinol. 2010;151:549–60. https://doi.org/10.1210/en.2009-0471.CrossRef

51.

Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol. 2005;11:3431–40. https://doi.org/10.3748/wjg.v11.i22.3431.

52.

Yin Y, Hao H, Cheng Y, Gao J, Liu J, Xie Z, et al. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice. Int Immunopharmacol. 2018;60:235–45. https://doi.org/10.1016/j.intimp.2018.04.051.

Title: Impact of combined therapy of mesenchymal stem cells and sitagliptin on a metabolic syndrome rat model
Authors: Yossra Ahmed
Zeinab Y. Ali
Mona A. Mohamed
Laila A. Rashed
Ehsan K. Mohamed
Publication date: 01-06-2021
Publisher: Springer International Publishing
Keywords: Sitagliptin
Insulins
Insulins
Published in: Journal of Diabetes & Metabolic Disorders / Issue 1/2021
Electronic ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-021-00778-3

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Effects of propolis supplementation on glycemic status, lipid profiles, inflammation and oxidative stress, liver enzymes, and body weight: a systematic review and meta-analysis of randomized controlled clinical trials

The synergistic effect of vitamin D supplement and mindfulness training on pain severity, pain-related disability and neuropathy-specific quality of life dimensions in painful diabetic neuropathy: a randomized clinical trial with placebo-controlled

Diabetes and rhino-orbito-cerebral mucormycosis – A deadly duo

Propolis ethanol extract abrogates hyperglycemia, lipotoxicity, and lowered hepatic poly (ADP-ribose) polymerase protein level in male albino rats

Establishment of biobank facility at Endocrinology and Metabolism Research Institute of Iran: experiences, challenges, and future outlook

Cardiovascular diseases risk prediction in patients with diabetes: Posthoc analysis from a matched case-control study in Bangladesh

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage